PE20020408A1 - Alcanosulfonatos de fenoxifenilo como agonistas del receptor de cannabinoides - Google Patents
Alcanosulfonatos de fenoxifenilo como agonistas del receptor de cannabinoidesInfo
- Publication number
- PE20020408A1 PE20020408A1 PE2001000958A PE2001000958A PE20020408A1 PE 20020408 A1 PE20020408 A1 PE 20020408A1 PE 2001000958 A PE2001000958 A PE 2001000958A PE 2001000958 A PE2001000958 A PE 2001000958A PE 20020408 A1 PE20020408 A1 PE 20020408A1
- Authority
- PE
- Peru
- Prior art keywords
- phenoxyphenyl
- receptor agonists
- cannabinoid receptor
- halogen
- alkanosulphonates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/63—Esters of sulfonic acids
- C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
- C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
- C07C309/20—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic unsaturated carbon skeleton
- C07C309/22—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic unsaturated carbon skeleton containing carboxyl groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/09—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton the carbon skeleton being further substituted by at least two halogen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Pulmonology (AREA)
- Ophthalmology & Optometry (AREA)
- Immunology (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Rheumatology (AREA)
- Psychology (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Otolaryngology (AREA)
- Nutrition Science (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
SE REFIERE A COMPUESTOS ALCANOSULFONATOS DE FENOXIFENILO DE FORMULA I DONDE R1 ES H, ALQUILO C1-C4, HALOGENO, TRIFLUOROMETILO, TRIFLUOROMETOXI, CIANO, NITRO; R2 ES HALOGENO, TRIFLUROMETILO, TRIFLUROMETOXI, CIANO, NITRO; R3 ES ALQUILO C4-C7; R4 ES H, HALOGENO; A ES O, NH. SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION. SON COMPUESTOS PREFERIDOS 3-METOXI-1-(3-METIL-2-NITROFENOXI)BENCENO, 3-METOXI-1-(2(TRIFLUOROMETIL)FENOXI)BENCENO, 1-[2-CIANO-3-(TRIFLUOROMETIL)FENOXI]-3-METOXIBENCENO, 1-[2-CLORO-3-(TRIFLUOROMETIL)FENOXI]-3-NITROBENCENO, ENTRE OTROS. LOS COMPUESTOS MENCIONADOS SON AGONISTAS DEL RECEPTOR DE CANNABINOIDES Y SON UTILES PARA EL TRATAMIENTO DE EMESIS, ANOREXIA, GLAUCOMA
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10047486A DE10047486A1 (de) | 2000-09-26 | 2000-09-26 | Phenoxyphenyl Alkansulfonate |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20020408A1 true PE20020408A1 (es) | 2002-06-08 |
Family
ID=7657564
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2001000958A PE20020408A1 (es) | 2000-09-26 | 2001-09-25 | Alcanosulfonatos de fenoxifenilo como agonistas del receptor de cannabinoides |
Country Status (34)
Country | Link |
---|---|
US (2) | US6756409B2 (es) |
EP (1) | EP1334086B1 (es) |
JP (1) | JP2004509946A (es) |
KR (1) | KR20030039372A (es) |
CN (1) | CN1476427A (es) |
AR (1) | AR033575A1 (es) |
AT (1) | ATE292621T1 (es) |
AU (2) | AU2002220547B2 (es) |
BG (1) | BG107634A (es) |
BR (1) | BR0114182A (es) |
CA (1) | CA2423171A1 (es) |
DE (2) | DE10047486A1 (es) |
EE (1) | EE200300117A (es) |
ES (1) | ES2240543T3 (es) |
GT (1) | GT200100193A (es) |
HN (1) | HN2001000214A (es) |
HR (1) | HRP20030326A2 (es) |
HU (1) | HUP0302258A3 (es) |
IL (1) | IL154968A0 (es) |
MA (1) | MA26053A1 (es) |
MX (1) | MXPA03002546A (es) |
NO (1) | NO20031357L (es) |
NZ (1) | NZ524886A (es) |
PE (1) | PE20020408A1 (es) |
PL (1) | PL361015A1 (es) |
PT (1) | PT1334086E (es) |
RU (1) | RU2278853C2 (es) |
SI (1) | SI1334086T1 (es) |
SK (1) | SK3442003A3 (es) |
SV (1) | SV2002000639A (es) |
UA (1) | UA75369C2 (es) |
UY (1) | UY26945A1 (es) |
WO (1) | WO2002026702A1 (es) |
ZA (1) | ZA200302275B (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003061699A1 (fr) * | 2001-12-27 | 2003-07-31 | Japan Tobacco, Inc. | Remedes pour affections allergiques |
EP2313093A4 (en) | 2008-07-10 | 2012-03-28 | Angion Biomedica Corp | METHOD AND COMPOSITIONS FOR LOW-MOLECULAR MODULATORS OF THE HEPATOCYTE GROWTH FACTOR (SCATTER FACTOR) ACTIVITY |
US10709497B2 (en) * | 2017-09-22 | 2020-07-14 | Covidien Lp | Electrosurgical tissue sealing device with non-stick coating |
CN114026085A (zh) | 2019-04-11 | 2022-02-08 | 安吉昂生物医药公司 | (e)-3-[2-(2-噻吩基)乙烯基]-1h-吡唑的固体形式 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE216642C (es) * | ||||
BE786644A (fr) * | 1971-07-23 | 1973-01-24 | Hoechst Ag | Derives d'acides phenoxy-4 phenoxy-alcane-carboxyliques leur preparation et les medicaments qui en contiennent |
US3914418A (en) * | 1971-09-02 | 1975-10-21 | Merck & Co Inc | Methods of controlling liver fluke infections |
GB8914660D0 (en) * | 1989-06-26 | 1989-08-16 | Fujisawa Pharmaceutical Co | Aniline derivatives,processes for production thereof and pharmaceutical compositions comprising the same |
IN186119B (es) * | 1996-07-25 | 2001-06-23 | Lg Chemical Ltd | |
US6090839A (en) * | 1996-12-23 | 2000-07-18 | Merck & Co., Inc. | Antidiabetic agents |
CZ300754B6 (cs) * | 1997-02-21 | 2009-08-05 | Bayer Aktiengesellschaft | Arylsulfonamidy a jejich analogy, zpusob jejich výroby, meziprodukty pro jejich výrobu, farmaceutické prostredky tyto látky obsahující a jejich použití |
US5925654A (en) * | 1997-03-12 | 1999-07-20 | G.D. Searle & Co. | LTA4 , hydrolase inhibitors |
ES2191341T3 (es) * | 1997-10-20 | 2003-09-01 | Taisho Pharmaceutical Co Ltd | Derivados de la 2-fenoxianilina. |
US6231875B1 (en) * | 1998-03-31 | 2001-05-15 | Johnson & Johnson Consumer Companies, Inc. | Acidified composition for topical treatment of nail and skin conditions |
NL1008795C2 (nl) * | 1998-04-02 | 1999-10-05 | Rene Werenfridus Lodewijk Vroo | Samenstelling voor het behandelen van hoeven en werkwijze voor het vervaardigen van de samenstelling. |
DE19837627A1 (de) * | 1998-08-19 | 2000-02-24 | Bayer Ag | Neue Aminosäureester von Arylsulfonamiden und Analoga |
HN1998000027A (es) * | 1998-08-19 | 1999-06-02 | Bayer Ip Gmbh | Arilsulfonamidas y analagos |
US6242422B1 (en) * | 1998-10-22 | 2001-06-05 | Idun Pharmacueticals, Inc. | (Substituted)Acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases |
-
2000
- 2000-09-26 DE DE10047486A patent/DE10047486A1/de not_active Withdrawn
-
2001
- 2001-09-13 RU RU2003112454/04A patent/RU2278853C2/ru not_active IP Right Cessation
- 2001-09-13 ES ES01985700T patent/ES2240543T3/es not_active Expired - Lifetime
- 2001-09-13 CN CNA01819527XA patent/CN1476427A/zh active Pending
- 2001-09-13 SK SK344-2003A patent/SK3442003A3/sk unknown
- 2001-09-13 HU HU0302258A patent/HUP0302258A3/hu unknown
- 2001-09-13 JP JP2002531088A patent/JP2004509946A/ja active Pending
- 2001-09-13 EP EP01985700A patent/EP1334086B1/de not_active Expired - Lifetime
- 2001-09-13 SI SI200130356T patent/SI1334086T1/xx unknown
- 2001-09-13 KR KR10-2003-7003902A patent/KR20030039372A/ko not_active Application Discontinuation
- 2001-09-13 PL PL01361015A patent/PL361015A1/xx not_active Application Discontinuation
- 2001-09-13 WO PCT/EP2001/010564 patent/WO2002026702A1/de active IP Right Grant
- 2001-09-13 AT AT01985700T patent/ATE292621T1/de not_active IP Right Cessation
- 2001-09-13 AU AU2002220547A patent/AU2002220547B2/en not_active Ceased
- 2001-09-13 IL IL15496801A patent/IL154968A0/xx unknown
- 2001-09-13 AU AU2054702A patent/AU2054702A/xx active Pending
- 2001-09-13 NZ NZ524886A patent/NZ524886A/en unknown
- 2001-09-13 DE DE50105857T patent/DE50105857D1/de not_active Expired - Fee Related
- 2001-09-13 UA UA2003043896A patent/UA75369C2/uk unknown
- 2001-09-13 CA CA002423171A patent/CA2423171A1/en not_active Abandoned
- 2001-09-13 MX MXPA03002546A patent/MXPA03002546A/es active IP Right Grant
- 2001-09-13 PT PT01985700T patent/PT1334086E/pt unknown
- 2001-09-13 BR BR0114182-1A patent/BR0114182A/pt not_active IP Right Cessation
- 2001-09-13 EE EEP200300117A patent/EE200300117A/xx unknown
- 2001-09-24 GT GT200100193A patent/GT200100193A/es unknown
- 2001-09-24 UY UY26945A patent/UY26945A1/es not_active Application Discontinuation
- 2001-09-24 AR ARP010104486A patent/AR033575A1/es not_active Application Discontinuation
- 2001-09-25 HN HN2001000214A patent/HN2001000214A/es unknown
- 2001-09-25 SV SV2001000639A patent/SV2002000639A/es unknown
- 2001-09-25 PE PE2001000958A patent/PE20020408A1/es not_active Application Discontinuation
- 2001-09-26 US US09/965,708 patent/US6756409B2/en not_active Expired - Fee Related
-
2003
- 2003-03-13 BG BG107634A patent/BG107634A/bg unknown
- 2003-03-24 ZA ZA200302275A patent/ZA200302275B/en unknown
- 2003-03-25 MA MA27075A patent/MA26053A1/fr unknown
- 2003-03-25 NO NO20031357A patent/NO20031357L/no not_active Application Discontinuation
- 2003-04-25 HR HR20030326A patent/HRP20030326A2/hr not_active Application Discontinuation
-
2004
- 2004-05-20 US US10/850,507 patent/US20040214886A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20030119A1 (es) | Derivados de 4-piperazinil indol con afinidad por el receptor 5-ht6 | |
PE20031011A1 (es) | Derivados de dihidrobenzodiazepin-2-ona-iii | |
PE20020541A1 (es) | Agonistas del receptor b3-adrenergico y usos de los mismos | |
PE20001483A1 (es) | Acidos oxamicos y derivados como ligandos de receptores tiroideos | |
PE20020753A1 (es) | Heteroaromaticos fusionados como activadores de la glucoquinasa | |
PE20060627A1 (es) | Derivados de pirazol condensado como agonistas de los receptores cannabinoides cb1 y/o cb2 | |
PE20010681A1 (es) | Derivados de benzodiazepina como antagonistas del receptor de glutamato metabotropico | |
PE20070519A1 (es) | Derivados de fenilmorfolina y feniltiomorfolina como agonistas de adrenoreceptores alfa 2c | |
PE20001088A1 (es) | Compuestos derivados de tetrahidrobenzazepina | |
PE20010009A1 (es) | Derivados de fenil - y piridinilo como antagonistas del receptor de la neuroquinina 1 | |
PE20000728A1 (es) | Heterociclos 4-bencil piperidina alquilsulfoxido y su uso como antagonistas receptores subtipo-selectivo nmda | |
PE20020230A1 (es) | Antiinflamatorios no-esteroides | |
PE20001467A1 (es) | Derivados de 4-fenilpiridina como antagonistas del receptor de neuroquinina | |
PE20010759A1 (es) | Derivados de benzodiazepina como antagonistas del receptor de glutamato metabotropico | |
PE20061298A1 (es) | Compuestos derivados de dihidrobenzofurano como agonistas del receptor de serotonina 5-ht2c | |
PE20061144A1 (es) | DERIVADOS DE PIRROLIDINA Y PIPERIDINA ACETILENO COMO ANTAGONISTAS DE LOS RECEPTORES DE GLUTAMATO METABOTROPICO (mGluRs) | |
PE20050193A1 (es) | Compuestos heterociclicos utiles como activadores de nurr-1 | |
PE20040672A1 (es) | Derivados de fenil o heteroaril amino alcano | |
PE20020657A1 (es) | Derivados de amida de piperidinas 1,4-disustituidas de formula (i) | |
PE59999A1 (es) | Derivados de 1,3,8-triaza-espiro[4,5]decan-4-ona-8-sustituidos | |
PE20040120A1 (es) | Derivados de quinolina como antagonistas de npy | |
PE20010039A1 (es) | Derivados de esteres del acido carbamico como agonistas y/o antagonistas del receptor metabotropico del glutamato | |
PE20030238A1 (es) | Uso de los antagonistas del receptor nk-1 para el tratamiento de lesiones cerebrales, espinales y neuronales | |
PE16299A1 (es) | Compuestos de 2-imidazolinilaminoindol utiles como agonistas de alfa-2 adrenoreceptores | |
PE20060770A1 (es) | Derivados de n-[(4,5-difenil-3-alquil-2-tienil)metil]amina como antagonistas de los receptores cannabinoides cb1 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration | ||
FD | Application declared void or lapsed |